These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 18852190)

  • 1. Peripheral vascular calcification in long-haemodialysis patients: associated factors and survival consequences.
    Jean G; Bresson E; Terrat JC; Vanel T; Hurot JM; Lorriaux C; Mayor B; Chazot C
    Nephrol Dial Transplant; 2009 Mar; 24(3):948-55. PubMed ID: 18852190
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serological cardiovascular and mortality risk predictors in dialysis patients receiving sevelamer: a prospective study.
    Brandenburg VM; Schlieper G; Heussen N; Holzmann S; Busch B; Evenepoel P; Vanholder R; Meijers B; Meert N; Fassbender WJ; Floege J; Jahnen-Dechent W; Ketteler M
    Nephrol Dial Transplant; 2010 Aug; 25(8):2672-9. PubMed ID: 20172849
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High levels of serum fibroblast growth factor (FGF)-23 are associated with increased mortality in long haemodialysis patients.
    Jean G; Terrat JC; Vanel T; Hurot JM; Lorriaux C; Mayor B; Chazot C
    Nephrol Dial Transplant; 2009 Sep; 24(9):2792-6. PubMed ID: 19395730
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of sevelamer on the progression of vascular calcification in patients on chronic haemodialysis.
    Takei T; Otsubo S; Uchida K; Matsugami K; Mimuro T; Kabaya T; Akiba T; Nitta K
    Nephron Clin Pract; 2008; 108(4):c278-83. PubMed ID: 18434749
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fibroblast growth factor-23 (FGF-23) is independently correlated to aortic calcification in haemodialysis patients.
    Nasrallah MM; El-Shehaby AR; Salem MM; Osman NA; El Sheikh E; Sharaf El Din UA
    Nephrol Dial Transplant; 2010 Aug; 25(8):2679-85. PubMed ID: 20176609
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lateral lumbar X-ray assessment of abdominal aortic calcification in Australian haemodialysis patients.
    Toussaint ND; Pedagogos E; Lau KK; Heinze S; Becker GJ; Beavis J; Polkinghorne KR; Damasiewicz MJ; Kerr PG
    Nephrology (Carlton); 2011 May; 16(4):389-95. PubMed ID: 21054667
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vascular calcifications and renal osteodystrophy in chronic hemodialysis patients: what is the relationship between them?
    Moldovan D; Moldovan I; Rusu C; Racasan S; Patiu IM; Brumboiu A; Bondor C; Parvu L; Kacso I; Orasan R; Gherman-Caprioara M
    Int Urol Nephrol; 2011 Dec; 43(4):1179-86. PubMed ID: 20862543
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ten-year experience with sevelamer and calcium salts as phosphate binders.
    Raggi P; Vukicevic S; Moysés RM; Wesseling K; Spiegel DM
    Clin J Am Soc Nephrol; 2010 Jan; 5 Suppl 1():S31-40. PubMed ID: 20089501
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Osteoprotegerin and progression of coronary and aortic calcifications in chronic kidney disease.
    Mesquita M; Demulder A; Wolff F; Mélot C; Damry N; Dratwa M; Bergmann P
    Transplant Proc; 2010 Nov; 42(9):3444-9. PubMed ID: 21094794
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Upper limb vascular calcification score as a predictor of mortality in diabetic hemodialysis patients.
    Georgiadis GS; Argyriou C; Antoniou GA; Kantartzi K; Kriki P; Theodoridis M; Thodis E; Lazarides MK
    J Vasc Surg; 2015 Jun; 61(6):1529-37. PubMed ID: 25724616
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Factors associated with various arterial calcifications in haemodialysis patients.
    Gelev S; Spasovski G; Trajkovski Z; Damjanovski G; Amitov V; Selim G; Dzekova P; Sikole A
    Prilozi; 2008 Dec; 29(2):185-199. PubMed ID: 19259046
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Attenuation of aortic calcification with lanthanum carbonate versus calcium-based phosphate binders in haemodialysis: A pilot randomized controlled trial.
    Toussaint ND; Lau KK; Polkinghorne KR; Kerr PG
    Nephrology (Carlton); 2011 Mar; 16(3):290-8. PubMed ID: 21342323
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Measurement of vascular calcification using CT fistulograms.
    Toussaint ND; Lau KK; Polkinghorne KR; Kerr PG
    Nephrol Dial Transplant; 2007 Feb; 22(2):484-90. PubMed ID: 17090606
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased levels of serum parathyroid hormone and fibroblast growth factor-23 are the main factors associated with the progression of vascular calcification in long-hour hemodialysis patients.
    Jean G; Bresson E; Lorriaux C; Mayor B; Hurot JM; Deleaval P; Chazot C
    Nephron Clin Pract; 2012; 120(3):c132-8. PubMed ID: 22584463
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term sevelamer treatment lowers serum fibroblast growth factor 23 accompanied with increasing serum Klotho levels in chronic haemodialysis patients.
    Lin HH; Liou HH; Wu MS; Lin CY; Huang CC
    Nephrology (Carlton); 2014 Nov; 19(11):672-8. PubMed ID: 25113414
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Associations between vascular calcification, arterial stiffness and bone mineral density in chronic kidney disease.
    Toussaint ND; Lau KK; Strauss BJ; Polkinghorne KR; Kerr PG
    Nephrol Dial Transplant; 2008 Feb; 23(2):586-93. PubMed ID: 17933842
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Changes in mineral metabolism in stage 3, 4, and 5 chronic kidney disease (not on dialysis)].
    Lorenzo Sellares V; Torregrosa V
    Nefrologia; 2008; 28 Suppl 3():67-78. PubMed ID: 19018742
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A plain X-ray vascular calcification score is associated with arterial stiffness and mortality in dialysis patients.
    Adragão T; Pires A; Birne R; Curto JD; Lucas C; Gonçalves M; Negrão AP
    Nephrol Dial Transplant; 2009 Mar; 24(3):997-1002. PubMed ID: 18952701
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association between very low PTH levels and poor survival rates in haemodialysis patients: results from the French ARNOS cohort.
    Jean G; Lataillade D; Genet L; Legrand E; Kuentz F; Moreau-Gaudry X; Fouque D;
    Nephron Clin Pract; 2011; 118(2):c211-6. PubMed ID: 21178378
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of efficacy of the phosphate binders nicotinic acid and sevelamer hydrochloride in hemodialysis patients.
    Ahmadi F; Shamekhi F; Lessan-Pezeshki M; Khatami MR
    Saudi J Kidney Dis Transpl; 2012 Sep; 23(5):934-8. PubMed ID: 22982903
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.